Dr. Mazdak Momeni, MD

Dr. Momeni practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Momeni's NPI, 1275865917, was assigned on February 5, 2010. Dr. Momeni holds California license A131261.

Dr. Momeni's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Momeni's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Momeni to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Momeni practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Momeni's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Momeni is licensed in California.

CMS data shows 259 Medicare services from Dr. Momeni across 5 procedure codes in 2024, for 97 Medicare patients. Medicare paid $24,203 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Momeni in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Momeni's median patient age at 62, with 99% women.

In 2024, Dr. Momeni wrote 255 Medicare Part D claims for 62 patients. 85% of them were for generic drugs. CMS names the drug for 161 of them, across 7 drugs with 11 or more claims each, at $5,569 in total drug cost. In 2023, CMS named 197 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Momeni for performance year 2024, reported as part of a group. Dr. Momeni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Momeni as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Momeni, published from 2012 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Gynecologic Surgical Procedures and Biomarkers, Tumor. Dr. Momeni has published most often in J Minim Invasive Gynecol. Dr. Momeni's most frequent co-authors are Linus Tsu-Huang Chuang, MD, Konstantin Zakashansky, MD and David A. Fishman, MD.

CMS Open Payments shows 40 general payments to Dr. Momeni from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Merck Sharp & Dohme Corporation paid the most, $17,093.